Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Fortesta,testim, androderm
Synonyms :
Testosterone topical
Class :
Androgens
Dosage Forms & StrengthsÂ
Transdermal patch, schedule IIIÂ
4mg/24hrÂ
2mg/24hrÂ
Androderm
Initial dose:4mg/day; apply a patch to abdomen, thigh, back, and arm at bedtime
Dosing range:2-6mg/day
Androgel
1%
50mg/day initially. Do not exceed 100mg/day
1.62%
40.5mg/day initially, apply to shoulders every morning
Testim
50mg/day initially, apply to shoulders every morning. Do not exceed 100mg/day
Axiron
60mg/day initially, apply to the axilla
Fortesta
40 mg/day initially, apply to thighs every morning
Dosage Forms & StrengthsÂ
Safety and efficacy not establishedÂ
Refer adult dosingÂ
may increase the myelosuppressive effect
may increase the anti-coagulant effect of androgens
may increase the anti-coagulant effect of androgens
may increase the anti-coagulant effect of androgens
may increase the anti-coagulant effect of androgens
may increase the anti-coagulant effect of androgens
may increase the hypoglycaemic effect of androgens
may increase the hypoglycaemic effect of androgens
may increase the hypoglycaemic effect of androgens
may increase the hypoglycaemic effect of androgens
may increase the hypoglycaemic effect of androgens
may increase the toxic effect
may increase the fluid retaining effect
may increase the fluid retaining effect
may increase the fluid retaining effect
may increase the fluid retaining effect
may increase the fluid retaining effect
may increase the hypertensive effect
may increase the hypertensive effect
may increase the hypertensive effect
may increase the hypertensive effect
may increase the hypertensive effect
Frequency defined:Â Â
>10%Â
Reaction at the application siteÂ
Blisters under skinÂ
PruritisÂ
1-10%Â
Vesicles at the application siteÂ
BurningÂ
ErythemaÂ
Allergic contact dermatitisÂ
IndurationÂ
Frequency not definedÂ
AcneÂ
Bladder irritabilityÂ
Cholestatic jaundiceÂ
Dry skinÂ
GynecomastiaÂ
InsomniaÂ
PriapismÂ
VirilizationÂ
Abnormal dreamsÂ
AnaphylaxisÂ
Breast sorenessÂ
Deep vein thrombosisÂ
FatigueÂ
HeadacheÂ
Post-marketing reportsÂ
Myocardial infarctionÂ
Venous thromboembolismÂ
PolycythemiaÂ
Pregnancy consideration: Insufficient data availableÂ
Lactation: Excretion of the drug in human breast milk is unknown Â
Pregnancy category:Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.  Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this categoryÂ
Patient information leafletÂ
Generic Name: Testosterone topicalÂ
Pronounced: [ tes-TOS-ter-one-TOP-i-kal ]Â
Why do we use Testosterone topical?Â
It is used to treat hypogonadism (a condition where testosterone is not produced naturally)Â